Characterization of Nanoparticles Intended for Drug Delivery (Record no. 7389)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04805nam a22005055i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-60327-198-1 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610083703.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 101130s2011 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781603271981 |
| -- | 978-1-60327-198-1 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-60327-198-1 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | TP248.13-248.65 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TCB |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | SCI010000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TCB |
| Source | thema |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 660.6 |
| Edition information | 23 |
| 245 10 - TITLE STATEMENT | |
| Title | Characterization of Nanoparticles Intended for Drug Delivery |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Scott E. McNeil. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. 2011. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Totowa, NJ : |
| Name of producer, publisher, distributor, manufacturer | Humana Press : |
| -- | Imprint: Humana, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2011. |
| 300 ## - online resource | |
| Extent | XII, 269 p. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Methods in Molecular Biology, |
| International Standard Serial Number | 1940-6029 ; |
| Volume/sequential designation | 697 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics -- Challenges for Nanoparticle Characterization -- Considerations when submitting nano-therapeutics to FDA/CDER for regulatory review -- Measuring the Hydrodynamic Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering -- Characterization of Nanoparticles by Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry -- Zeta Potential Measurement -- Size Measurement of Nanoparticles using Atomic Force Microscopy -- Biological Tissue and Cell Culture Specimen Preparation for TEM Nanoparticle Characterization.– SEM X-ray Microanalysis of Nanoparticles Present in Tissue or Cultured Cell Thin Sections -- Detecting and Measuring Free Gadolinium in Nanoparticles for MRI Imaging -- Lipid Component Quantitation by Thin Layer Chromatography -- Detection and Quantitative Evaluation of Endotoxin Contamination in Nanoparticle Formulations by LAL-based Assays -- Analysis of microbial contamination in nanoparticle formulations -- Gold Nanoparticle Quantitation via Fluorescence in Solution and Cell Culture -- Quantitation of Nanoparticles in Serum Matrix by Capillary Electrophoresis -- Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells -- Monitoring Nanoparticle-Treated Hepatacarcinoma Cells for Apoptosis – Detecting Reactive Oxygen Species in Primary Hepatocytes Treated with Nanoparticles -- Assay to Detect Lipid Peroxidation Upon Exposure to Nanoparticles -- Monitoring Glutathione Homeostasis in Nanoparticle-Treated Hepatocytes -- Autophagy Monitoring Assay: Qualitative Analysis of MAP LC3-I to II Conversion by Immunoblot -- Monitoring Lysosomal Activity in Nanoparticle-Treated Cells -- Method for Analysis of Nanoparticle Hemolytic Properties in Vitro -- Method for In Vitro Analysis of Nanoparticle Thrombogenic Properties -- Qualitative Analysis of Total Complement Activation by Nanoparticles -- Method for Analysis ofNanoparticle Effects on Cellular Chemotaxis -- In Vitro Analysis of Nanoparticle Uptake by Macrophages Using Chemiliuminescence. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | In recent years, there have been many exciting breakthroughs in the application of nanotechnology to medicine. In Characterization of Nanoparticles Intended for Drug Delivery, expert researchers explore the latest advances in the field, providing a set of basic methods for the characterization of nanomaterials for medical use. Chapters provide methods to characterize the physiochemical properties (size, aggregation, and surface chemistry) and in vitro immunological and biological characteristics of nanomaterials. Composed in the highly successful Methods in Molecular Biology™ series format, each chapter contains a brief introduction, step-by-step methods, a list of necessary materials, and a Notes section which shares tips on troubleshooting and avoiding known pitfalls. Comprehensive and informative, Characterization of Nanoparticles Intended for Drug Delivery is an essential survey of methods that are crucial to the preclinical characterization of nanomedicines. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacy. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biotechnology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nanotechnology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McNeil, Scott E. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer Nature eBook |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9781603271974 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9781607619086 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9781493961139 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Methods in Molecular Biology, |
| International Standard Serial Number | 1940-6029 ; |
| Volume/sequential designation | 697 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-1-60327-198-1">https://doi.org/10.1007/978-1-60327-198-1</a> |
| 912 ## - | |
| -- | ZDB-2-PRO |
No items available.